Pharmaceuticals & Medical Devices
Featured news
AIM WELCOMES THE EU CRITICAL MEDICINES ACT AS A STEP TOWARDS EQUITABLE ACCESS AND SUPPLY CHAIN RESILIENCE
The International Association of Mutual Benefit Societies (AIM) welcomes the recent publication of the EU Critical Medicines Act as a crucial initiative to strengthen equitable access to medicines acr......
STATEMENT ON THE EUROPEAN COMMISSION CALL FOR EVIDENCE ON THE CRITICAL MEDICINES ACT
In response to the Commission’s public consultation on the Critical Medicines Act, the International Association of Mutual Benefit Societies (AIM) has submitted its feedback. AIM welcomes the potent......
AIM successfully launches its Calculator for Fair Medicines Prices in Europe
The International Association of Mutual Benefit Societies (AIM) has launched today its calculator for fair medicines prices in Europe (German version here). The calculator transposes AIM's fair pricin......
Other news
Joint Statement on the Revision of the Pharmaceutical Legislation by associations representing healthcare providers, patients, healthcare professionals and payers
Enhancing patients’ access to high-quality and affordable medicinal...
“Better treatment for better health: lifting the veil on treatment optimisation” – Stakeholders exchange views on patient-centred clinical research at EORTC and AIM’s seminar
Treatment optimisation is defined as clinical research in real-world c...
European Commission opens its public consultation on the revision of the basic pharmaceutical legislation
On 28 September the European Commission opened its public consultation...
Payer involvement is important for a successful EU HTA framework!
The International Association of Mutual Benefit Societies (AIM) welcom...
AIM successfully launches its Calculator for Fair Medicines Prices in Europe
The International Association of Mutual Benefit Societies (AIM) has la...
World Health Day Declaration – International solidarity needs to play at full speed to ensure access to COVID-19 vaccines
This year’s World Health Day is placed under the motto “Building a...
The Pharmaceutical Strategy for the EU: A welcome set of actions but strong political leadership is needed
The European Commission has published its Communication on a Pharm...
Joint Statement – Transparency is needed to reap the full benefits of the EU’s investment in its Vaccines Strategy
Ahead of Friday 18 September's webinar the EU Vaccine Strategy, a numb...
Recommendations towards fair medicines prices in Europe
12 European and international organisations representing not-for-profi...